Evoke Pharma Inc., a specialty pharmaceutical company primarily focused on treatments for gastrointestinal (GI) diseases, and EVERSANA Life Science Service LLC, an independent provider of global commercial services to the life science industry, announced an extension of their agreement. The companies will continue collaborating on the commercialization and distribution of Gimoti (metoclopramide) nasal spray in the United States through the end of 2026.
Peregrine Market Access, a full-service life science commercialization partner, promoted Kathryn “Kat” Evans to director of client engagement. The new position elevates Evans to Peregrine’s senior leadership team at the fast-growing company.
Ashfield Engage, part of UDG Healthcare, announced the acquisition of Medaxis, a patient engagement services partner for the life sciences industry that provides services to healthcare professionals and patients.
Stephen Hoelper, President, North America at Doceree, analyzes why life sciences brands need to move beyond vanity metrics for point-of-care campaigns.
On January 17, America is celebrating the legendary life of civil rights leader Dr. Martin Luther King Jr. In 2022, the holiday comes in the wake of two years of racial tensions and protests, and the racial inequities exposed by the COVID-19 pandemic. BioSpace is marking the occasion by sharing some of its recent coverage about what the life sciences industry is doing to even those scales.
Is the life sciences industry a good bet right now? BioSpace put a poll in the field, which elicited mixed results. In order to get a clearer picture, BioSpace spoke to a few knowledgeable industry experts.
BioSpace presented its NextGen Bio “Class of 2022,” a list of up-and-coming life sciences companies in North America that recently launched.
2021 was an important year for the life sciences industry. From the continuing fight against COVID-19 to new companies emerging in exciting therapeutic areas to the people who mattered most, BioSpace looks at some of the biggest successes, most dramatic flops – and a few that fall somewhere in between.
Several life sciences companies and life science-focused real estate firms announced expansion plans as 2021 comes to an end.
With the Thanksgiving holiday upon us, BioSpace felt it was important to give thanks for some of the positive things that have happened during 2021. And there are many! The accomplishments, opportunities and possibilities the scientific community has brought to bear, providing a way out of the COVID-19 pandemic and hope for the future of meaningful therapies for several challenging diseases, deserve a major shout-out.
